References
- Gibofsky A. Overview of epidemiology, pathophysiology, and diagnosis of rheumatoid arthritis. Am J Manag Care 2012;18:S295-S302
- Helmick CG, Felson DT, Lawrence RC, et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I. Arthritis Rheum 2008;58:15-25
- Myasoedova E, Crowson CS, Kremers HM, et al. Is the incidence of rheumatoid arthritis rising? Results from Olmsted County, Minnesota, 1955–2007. Arthritis Rheum 2010;62:1576-82
- Hayter SM, Cook MC. Updated assessment of the prevalence, spectrum and case definition of autoimmune disease. Autoimmun Rev 2012;11:754-65
- Scott DL, Wolfe F, Huizinga TWJ. Rheumatoid arthritis. Lancet 2010;376:1094-108
- McInnes IB, Schett G. The pathogenesis of rheumatoid arthritis. N Engl J Med 2011;365:2205-19
- Cooper NJ. Economic burden of rheumatoid arthritis: a systematic review. Rheumatology 2000;39:28-33
- Fautrel B, Clarke AE, Guillemin F, et al. Costs of rheumatoid arthritis: new estimates from the human capital method and comparison to the willingness-to-pay method. Med Decis Making 2007;27:138-50
- Bansback N, Zhang W, Walsh D, et al. Factors associated with absenteeism, presenteeism, and activity impairment in the first years of RA. Rheumatology 2012;15:375-84
- Committee on Quality Health Care in America, Institute of Medicine. Crossing the quality chasm: a new health system for the 21st century. Washington, DC: National Academy Press; 2001
- Scott DGI, Moots R, Dasgupta B, et al. Comparison of staff resources and patient time required for rituximab and infliximab administration in 3 UK NHS hospitals. Value Health 2009;12:A445
- Pierce CA, Baker JJ. A nursing process model: quantifying infusion therapy resource consumption. J Infus Nursing 2004;27:232-44
- Atkinson MJ, Sinha A, Hass SL, et al. Validation of a general measure of treatment satisfaction, the Treatment Satisfaction Questionnaire for Medication (TSQM), using a national panel study of chronic disease. Health Qual Life Outcomes 2004;2:12
- Fraser I, Encinosa W, Glied S. Improving efficiency and value in health care: introduction. Health Serv Res 2008;43:1781-6
- Palmer S, Torgerson DJ. Economic notes: definitions of efficiency. BMJ 1999;318:1136
- Ellis L, Malangone-Monaco E, Varker H, et al. Budgetary impact analysis of real-world dosing patterns in matched cohorts of rheumatoid arthritis patients treated with infliximab or golimumab intravenous anti-tumor necrosis factor medications. J Manag Care Pharm 2017;23:S72